XBiotech XBIT
NASDAQ XBIT
$1.91 +0.04 (+2.14%)
At close: Nov 9, 2026 · 4:00 PM EST

XBiotech (XBIT) Receivables - Net (2020 - 2025)

Updated

Analysis

XBiotech (XBIT) Receivables - Net (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 XBiotech 58.23 Mn -439.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 450,000.00
Jun 30, 2025 480,000.00
Mar 31, 2025 480,000.00
Dec 31, 2024 700,000.00
Sep 30, 2024 730,000.00
Jun 30, 2024 870,000.00
Mar 31, 2024 870,000.00
Dec 31, 2023 860,000.00
Sep 30, 2023 881,000.00
Dec 31, 2022 1.22 Mn
Sep 30, 2022 1.53 Mn
Mar 31, 2022 500,000.00
Sep 30, 2021 44,000.00
Jun 30, 2021 25,000.00
Mar 31, 2021 1.69 Mn
Dec 31, 2020 4.11 Mn
Sep 30, 2020 6.06 Mn
Jun 30, 2020 20.68 Mn
Mar 31, 2020 9.68 Mn
API Access

XBiotech Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=XBIT&period=max&api_key=YOUR_API_KEY